Nuwellis Inc (NUWE) Stock Price, Quote & News

Company Profile

Nuwellis, Inc., a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company offers Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure. Its Aquadex FlexFlow system includes a console, disposable blood circuit set, and disposable catheter. The company sells its products to hospitals and clinics through its direct salesforce in the United States; and...

Industry: Medical Devices

Sector: Healthcare

Phone: 952 345 4200

Website: www.nuwellis.com

Address:

12988 Valley View Road, Eden Prairie, United States

PaulLaurent Jul. 7 at 6:16 AM

📌 Reverse Splits – Effective July 7, 2025 $REVB (Revelation Biosciences): 1-for-3 reverse split. Each 3 shares consolidated into 1. Warrants and RSUs adjusted accordingly. $NUWE (Nuwellis Inc.): 1-for-42 reverse split. Shares now trading on a split-adjusted basis to regain Nasdaq compliance. $LVLU (Lulus Fashion Lounge): 1-for-15 reverse split. Implemented to increase share price and maintain listing standards. $LRHC (La Rosa Holdings): 1-for-80 reverse split. Outstanding shares reduced from ~58.3M to ~729K. Now trading post-split. $FLYE (Fly-E Group): 1-for-5 reverse split. Strategic float restructuring to meet exchange requirements. CYCC (Cyclacel Pharmaceuticals): 1-for-15 reverse split. Executed to address bid price compliance and optimize capital structure. BIVI (BioVie Inc.): 1-for-10 reverse split. Enacted to strengthen share price and meet continued listing rules.

0 · Reply

NUWE_to_the_moon Jul. 6 at 11:59 PM

$NUWE last year's reverse split got at 50-60% (4->6.6) pop intraday, lets see if history repeats! Lets get a squezze +100% move

0 · Reply

StockHits8 Jul. 6 at 9:19 PM

$NUWE on mega high watch Monday! They might get delisted soon float after R/S is either 89,000 or 104,000 either way smallest float ever and shorts 🩳 must close positions! Epic Squeeze Monday cometh 💫 👀✅ it was #1 Highest Most Shorted Stock on Market Watch now #2

0 · Reply

bananna1 Jul. 6 at 6:11 PM

$NUWE ARQQ was trading at .27 they did the same thing reverse split I boughtit before and after split at $5 it hit a high of $55 they did this on purpose after hours to Halt and reverse split we open at $18 easy 25-30 next week short coverage.

2 · Reply

PaulLaurent Jul. 6 at 5:53 PM

🪙📉 Lowest Market Cap Stocks 📉🪙 $MULN $NUWE $SVRE $WLGS $LGHL

0 · Reply

VizTheWin Jul. 6 at 2:15 PM

$NUWE @WAYWARD_SUN what do you think, 50% after rs is a good time to buy? Sending prayers for john.

1 · Reply

bananna1 Jul. 6 at 3:43 AM

$NUWE Small float Monday shorts are trapped big time. Wow, wow, maybe a run like we have never seen before. I would hate to be short with a 104,000 float.

0 · Reply

YasirTrades Jul. 5 at 9:18 PM

SSY is quietly setting up for something major. Ultra low float. No dilution. Trading under $1 with a massive merger catalyst in play. These types of setups don’t stay quiet forever when the trigger hits, they move fast and hard. Perfect storm brewing for those paying attention. $APRN $TIO $NUWE $SNTI

0 · Reply

CantNameThatTune Jul. 5 at 1:38 AM

$NUWE If this is correct it appears to be about 1 for 42. That means the outstanding shares are now 104,000. I've never seen one this low.

2 · Reply

CantNameThatTune Jul. 5 at 12:52 AM

$NUWE This is all rather bizarre. Halted news pending last night. Then the news hits of a Special Meeting a month from now where they will vote for a reverse split. The stock is already reverse split quoting $8.2446

3 · Reply

Nuwellis Appoints John Erb as Chief Executive Officer

Jun 10, 2025, 4:15 PM EDT - 26 days ago

Nuwellis Announces Closing of $5.0 Million Underwritten Public Offering Including Full Exercise of Overallotment Option

Jun 9, 2025, 9:15 AM EDT - 27 days ago

Nuwellis Announces Pricing of $4.3 Million Underwritten Public Offering

May 13, 2025, 10:50 AM EDT - 7 weeks ago

Nuwellis, Inc. (NUWE) Q1 2025 Earnings Call Transcript

May 13, 2025, 7:00 AM EDT - 7 weeks ago

Nuwellis, Inc. Reports First Quarter 2025 Financial Results and Business Highlights

May 12, 2025, 7:00 AM EDT - 7 weeks ago

Nuwellis Contracts with KDI Precision Manufacturing to Strengthen Production and Improve Operational Efficiency

May 8, 2025, 7:00 AM EDT - 2 months ago

Nuwellis Expands Aquadex® for Pediatric Fluid Management to Two New Hospital Systems

Apr 24, 2025, 7:00 AM EDT - 2 months ago

Nuwellis Expands IP Portfolio with Patent That Reduces Clinical Burden, Preserves Precision

Apr 22, 2025, 4:05 PM EDT - 2 months ago

Nuwellis, Inc. To Report First Quarter 2025 Financial Results on May 13, 2025

Mar 11, 2025, 12:23 PM EDT - 4 months ago

Nuwellis, Inc. (NUWE) Q4 2024 Earnings Call Transcript

Mar 11, 2025, 8:00 AM EDT - 4 months ago

Nuwellis, Inc. Announces Fourth Quarter and Full Year 2024 Financial Results

Feb 24, 2025, 4:05 PM EST - 4 months ago

Nuwellis Announces Retirement of Nestor Jaramillo, Jr. as President and CEO

Feb 20, 2025, 8:00 AM EST - 4 months ago

JACC: Heart Failure Paper Reports Promising Findings of Aquadex Therapy in Updated AVOID-HF Study Analysis

Feb 18, 2025, 4:15 PM EST - 4 months ago

Nuwellis, Inc. To Report Fourth Quarter and Full Year 2024 Financial Results on March 11, 2025

Dec 19, 2024, 9:00 AM EST - 7 months ago

Nuwellis Regains Compliance with Nasdaq Listing Requirements

Nov 11, 2024, 11:02 AM EST - 8 months ago

Nuwellis, Inc. (NUWE) Q3 2024 Earnings Call Transcript

Nov 11, 2024, 8:00 AM EST - 8 months ago

Nuwellis, Inc. Announces Third Quarter 2024 Financial Results and Recent Highlights

Nov 5, 2024, 9:28 AM EST - 8 months ago

Nuwellis Announces Exercise of Warrants for $5.1 Million of Gross Proceeds

Nov 4, 2024, 8:30 AM EST - 8 months ago

Nuwellis Receives Increased Reimbursement Rate for Aquadex SmartFlow® Therapy from the Centers for Medicare and Medicaid

Nov 1, 2024, 4:15 PM EDT - 8 months ago

Nuwellis Announces Preliminary Results for Third Quarter of 2024

Oct 31, 2024, 8:00 AM EDT - 8 months ago

Nuwellis Welcomes University of Iowa Health Care Stead Family Children's Hospital as Newest Pediatric Customer

Oct 23, 2024, 4:15 PM EDT - 9 months ago

Nuwellis, Inc. To Report Third Quarter 2024 Financial Results on November 11, 2024

Sep 25, 2024, 4:15 PM EDT - 10 months ago

Nuwellis to Present at the Third Annual ROTH Healthcare Opportunities Conference

Aug 23, 2024, 9:00 AM EDT - 11 months ago

Nuwellis Announces Pricing of $916,000 Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

Aug 13, 2024, 12:39 PM EDT - 11 months ago

Nuwellis, Inc. (NUWE) Q2 2024 Earnings Call Transcript

Aug 13, 2024, 8:00 AM EDT - 11 months ago

Nuwellis, Inc. Announces Second Quarter 2024 Financial Results

Jul 26, 2024, 9:00 AM EDT - 1 year ago

Nuwellis Announces First Pediatric Patient Treated in a Commercial Setting with SeaStar Medical's QUELIMMUNE™ Therapy at Cincinnati Children's

Jul 24, 2024, 8:02 AM EDT - 1 year ago

Nuwellis Announces Pricing of $2.0 Million Offering Priced At-The-Market Under Nasdaq Rules

Jul 23, 2024, 4:10 PM EDT - 1 year ago

Nuwellis, Inc. To Report Second Quarter 2024 Financial Results on August 13, 2024

Jul 17, 2024, 9:00 AM EDT - 1 year ago

Nuwellis Marks First Commercial Sale of QUELIMMUNE™ Therapy to Cincinnati Children's

Jun 26, 2024, 8:45 AM EDT - 1 year ago

Nuwellis Announces Reverse Stock Split

Jun 25, 2024, 9:00 AM EDT - 1 year ago

Nuwellis Secures New Patent for Innovative Pediatric Continuous Renal Replacement Therapy, Vivian™

Jun 11, 2024, 12:46 PM EDT - 1 year ago

DaVita, Nuwellis Extend Pilot Collaboration for Aquadex

DVA

Jun 6, 2024, 9:00 AM EDT - 1 year ago

Nuwellis and DaVita Extend Supply and Collaboration Agreement Pilot Phase

May 14, 2024, 9:00 AM EDT - 1 year ago

Nuwellis Announces Expansion of Ultrafiltration Program to Pediatric Patients at One of the Largest Hospital Networks in Florida

May 9, 2024, 9:00 AM EDT - 1 year ago

Nuwellis Announces Purchase Agreement with a 50 Hospital Network for Aquadex Ultrafiltration Therapy

May 7, 2024, 10:29 AM EDT - 1 year ago

Nuwellis, Inc. (NUWE) Q1 2024 Earnings Call Transcript

May 7, 2024, 8:00 AM EDT - 1 year ago

Nuwellis, Inc. Announces First Quarter 2024 Financial Results

Apr 30, 2024, 6:09 PM EDT - 1 year ago

Nuwellis Announces Closing of $2.7 Million Public Offering

Apr 30, 2024, 4:41 PM EDT - 1 year ago

Nuwellis, Inc. To Report First Quarter 2024 Financial Results on May 7, 2024

Apr 26, 2024, 9:17 AM EDT - 1 year ago

Nuwellis Announces Pricing of $2.7 Million Public Offering

Mar 7, 2024, 9:08 AM EST - 1 year ago

Late-Breaking Data Highlighting Benefits of Ultrafiltration Therapy Using the Aquadex System for Heart Failure Patients was Presented at the Technology and Heart Failure Therapeutics Conference

Mar 5, 2024, 12:11 PM EST - 1 year ago

Nuwellis, Inc. (NUWE) Q4 2023 Earnings Call Transcript

Mar 5, 2024, 8:00 AM EST - 1 year ago

Nuwellis, Inc. Announces Fourth Quarter and Full Year 2023 Financial Results

Feb 27, 2024, 9:00 AM EST - 1 year ago

Nuwellis, Inc. To Report Fourth Quarter and Full Year 2023 Financial Results on March 5, 2024

Feb 22, 2024, 7:58 AM EST - 1 year ago

Nuwellis' Distribution Partner, SeaStar Medical, Receives FDA Humanitarian Device Exemption for Pediatric Selective Cytopheretic Device Quelimmune™

Feb 20, 2024, 5:06 PM EST - 1 year ago

Nuwellis, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Feb 20, 2024, 8:42 AM EST - 1 year ago

Nuwellis to Announce Late-Breaking Clinical Data and Host Satellite Symposium at Technology and Heart Failure Therapeutics Conference

Feb 6, 2024, 9:00 AM EST - 1 year ago

New Case Series Demonstrates Potential of Aquadex Therapy for End-Stage Liver Disease Patients with Fluid Overload

Jan 4, 2024, 3:05 PM EST - 1 year ago

Nuwellis Receives FDA Clearance for an Additional Dual Lumen Extended Length Peripheral Catheter

PaulLaurent Jul. 7 at 6:16 AM

0 · Reply

NUWE_to_the_moon Jul. 6 at 11:59 PM

$NUWE last year's reverse split got at 50-60% (4->6.6) pop intraday, lets see if history repeats! Lets get a squezze +100% move

0 · Reply

StockHits8 Jul. 6 at 9:19 PM

0 · Reply

bananna1 Jul. 6 at 6:11 PM

2 · Reply

PaulLaurent Jul. 6 at 5:53 PM

🪙📉 Lowest Market Cap Stocks 📉🪙 $MULN $NUWE $SVRE $WLGS $LGHL

0 · Reply

VizTheWin Jul. 6 at 2:15 PM

$NUWE @WAYWARD_SUN what do you think, 50% after rs is a good time to buy? Sending prayers for john.

1 · Reply

bananna1 Jul. 6 at 3:43 AM

$NUWE Small float Monday shorts are trapped big time. Wow, wow, maybe a run like we have never seen before. I would hate to be short with a 104,000 float.

0 · Reply

YasirTrades Jul. 5 at 9:18 PM

0 · Reply

CantNameThatTune Jul. 5 at 1:38 AM

$NUWE If this is correct it appears to be about 1 for 42. That means the outstanding shares are now 104,000. I've never seen one this low.

2 · Reply

CantNameThatTune Jul. 5 at 12:52 AM

3 · Reply

GreenResearchers Jul. 4 at 11:49 PM

SSY is a hidden gem with serious upside. Float is microscopic. Trades under $1. No dilution, no games just a tight setup and a massive merger on deck. This is one of those tickers that looks quiet… until it isn’t. When it wakes up, it could move like a rocket. $CYN $TIRX $NUWE $IPWR …

0 · Reply

bananna1 Jul. 4 at 8:47 PM

$NUWE It will pop big time $$$$

0 · Reply

Bentradez Jul. 4 at 8:44 PM

$NUWE highest short interest! 82% short interest!

0 · Reply

Imr77 Jul. 4 at 8:22 PM

$NUWE when R/S? will it go down to 0.1?

1 · Reply

Zackpedia Jul. 4 at 1:16 PM

$NUWE RS proposal, should be going down to .13 support

0 · Reply

CautiousSloth Jul. 4 at 10:38 AM

$ICU insiders are loaded up, the device is commercialized, the company is virtually debt-free and just did a raise, no more $NUWE in the middle, taking their cut, and more potentially-positive catalysts on the way as new indications are approved & developed. It’s an easy hold from here - there’s already an endless line of buyers wanting to take my shares, I know, and they’re not for sale 🤙 Long weekends/holidays are hard because I love what I do so much. I hope to be in a financial position one day to be able to give away as much as I can unconditionally - that’s what we need more of in the world and that’s why I do this. Holding $CTM 🛡️ & $ESMC 👁️👁️ long and strong as well…

1 · Reply

martinwien Jul. 4 at 8:21 AM

$NUWE reverse split will be effective July 7th.

2 · Reply

YouVSYou Jul. 3 at 11:18 PM

$NUWE A special meeting of stockholders is scheduled for August 4, 2025, at 2:00 p.m. Central Time to vote on four proposals: (1) approval of issuing shares upon the exercise of warrants from a June 10, 2025 financing transaction (Warrant Exercise Proposal); (2) increasing the authorized common stock shares from 100 million to 200 million (Authorized Shares Increase Proposal); (3) approving a reverse stock split at a ratio between 1-for-5 and 1-for-70 to meet Nasdaq listing requirements, with the exact ratio and timing at the Board’s discretion (Reverse Split Proposal); and (4) authorizing adjournments of the meeting to solicit additional votes if needed.

0 · Reply

Mattherhorn Jul. 3 at 9:45 PM

$NUWE correct me if I am wrong - OS will be about 500k shares after they RS. They have an assload of warrants, but the stock is oversold? I could see this tank next week and then there could be a good opportunity to buy

0 · Reply

Bikinibullshark Jul. 3 at 6:56 PM

$WHLR $NUWE $IVF $MULN Dear stocktwits friends, There’s been a turn of events and now I’m battling cancer after all. I already knew before they told me, and I’m prepared to beat the F outta this, just like my father did!!! I’ll be here, just not as often because I have a lot of doctor’s appointments to go to. I love you all, especially the ones that have been here since the beginning. Some of you feel like family. 🫶🏼✨ Happy and safe 4th!!!

2 · Reply

OneSmartBull Jul. 3 at 5:49 PM

$NUWE - has dropped over 99% from its April 2024 high of $340.20 to under $1 by mid-2025 Bottom play.

0 · Reply

OneSmartBull Jul. 3 at 5:44 PM

$NUWE - Deep Value Play: - NUWE scores an 89/100 on value metrics, indicating it’s trading well below intrinsic value by traditional standards. - Unique Product Niche: Its Aquadex SmartFlow® system targets fluid overload in heart failure patients—a specialized but growing market. - Leadership Reset: The return of former CEO John Erb could bring operational discipline and strategic clarity. - Analyst Optimism: One analyst maintains a $17 price target, implying a staggering upside—but this is speculative and not widely echoed

0 · Reply

Market Cap	859,000.00
Revenue (ttm)	8.74M
Net Income (ttm)	-11.17M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-127.80%
Debt to Equity Ratio	0.00

Volume	2,246,300
Avg Vol	12,549,866
Day's Range	N/A - N/A
Shares Out	4.37M
Stochastic %K	5%
Beta	0.28
Analysts	Hold
Price Target	$11.00